Financial
Latest full-year results from official filings.
FY2025 revenue $20.62bn (+4.8%); operating margin 13.4%; net income $2.08bn.
Cash $4.51bn; debt $10.00bn.
- Official results release · GE HealthCare · 31 Dec 2025
GE HealthCare: risk summary
Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Adverse media
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
No adverse media involving GE HealthCare found in HSH's search of the last 24 months.
Cyber & information governance
Data breaches, cyber incidents, regulator action and assurance status.
Mar 2026: GE HealthCare began a US recall of certain Revolution CT systems over a potential security vulnerability in AW Server deployed via its Edison Health Link CT subscription. NHS DSPT status not yet checked.
- Class 2 Device Recall: Revolution CT (AW Server security vulnerability) · US FDA · 8 May 2026
Regulatory & clinical safety
Recalls, safety notices, regulator action and clinical safety concerns.
Aug 2026: GE HealthCare began a US Class 2 recall of some Senographe Pristina mammography systems, as a configuration issue could cause image artefacts or a minor extra x-ray dose.
- Class 2 Device Recall: Senographe Pristina · US FDA · 4 Nov 2026
Contract performance
Contract delivery, go-lives, terminations and disputes.
No notable contract disputes, terminations or troubled implementations involving GE HealthCare found in HSH's search of the last 24 months.